Page last updated: 2024-09-04

dc 015 and Hyperlipidemias

dc 015 has been researched along with Hyperlipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, YM; Peng, IH; Sheu, JR; Yen, MH	1

Other Studies

1 other study(ies) available for dc 015 and Hyperlipidemias

Article	Year
Effects of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rats. Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoproteins; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Prazosin; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY	1996

Article

Year

Effects of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rats.

Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:3

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoproteins; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Prazosin; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1996